SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-043965
Filing Date
2020-12-22
Accepted
2020-12-22 09:15:44
Documents
4
Period of Report
2020-12-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea132049-8k_soligenixinc.htm 8-K 18946
2 PRESS RELEASE OF SOLIGENIX, INC. DATED DECEMBER 22, 2020 ea132049ex99-1_soligenixinc.htm EX-99.1 26663
3 SOLIGENIX, INC. CONFERENCE CALL SCRIPT DATED DECEMBER 22, 2020 ea132049ex99-2_soligenixinc.htm EX-99.2 36666
4 GRAPHIC ex99-1_001.jpg GRAPHIC 21870
  Complete submission text file 0001213900-20-043965.txt   113924
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 201406294
SIC: 2834 Pharmaceutical Preparations